These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8625139)
1. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer. Le Péchoux C; Arriagada R; Le Chevalier T Cancer; 1995 Aug; 76(3):530-1. PubMed ID: 8625139 [No Abstract] [Full Text] [Related]
2. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer. Comella P; Scoppa G; Daponte A; Musetta G; Anania C; Maiorino A; Curcio C; Casaretti R; Comella G Cancer; 1994 Oct; 74(7):1874-81. PubMed ID: 8082093 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy consisting of epirubicin, cisplatin, and etoposide followed by irradiation in stage III non-small cell lung cancer and chemotherapy alone in stage IV non-small cell lung cancer. Wils J; Utama I; Smeets J Oncology; 1988; 45(6):413-6. PubMed ID: 2847098 [TBL] [Abstract][Full Text] [Related]
5. [Current data concerning neoadjuvant chemotherapy]. Depierre A Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S11-3. PubMed ID: 16719148 [No Abstract] [Full Text] [Related]
6. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer. Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368 [TBL] [Abstract][Full Text] [Related]
7. Role of small doses of radiotherapy combined with chemotherapy in non-small cell lung cancer. Dionet C; Verrelle P; Roux D; Fraysse P; Achard JL; Beaupain R; Rozan R Antibiot Chemother (1971); 1988; 41():163-7. PubMed ID: 2854436 [No Abstract] [Full Text] [Related]
8. Escalating paclitaxel doses combined with carboplatin/etoposide and thoracic radiotherapy as preoperative or definitive treatment for stage III non-small cell lung cancer. Bonomi P; Siddiqui S; Lincoln S; Sharma M; Recine D; Warren W; Faber LP Semin Oncol; 1996 Dec; 23(6 Suppl 16):102-7. PubMed ID: 9007134 [TBL] [Abstract][Full Text] [Related]
9. Long term results of surgery and chemotherapy in small cell lung cancer. Rea F; Callegaro D; Favaretto A; Loy M; Paccagnella A; Fantoni U; Festi G; Sartori F Eur J Cardiothorac Surg; 1998 Oct; 14(4):398-402. PubMed ID: 9845145 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of small cell lung cancer]. Ueoka H; Ohnoshi T Gan To Kagaku Ryoho; 1994 Nov; 21(15):2571-7. PubMed ID: 7979415 [TBL] [Abstract][Full Text] [Related]
11. In regard to hyperfractionation for non-small-cell lung cancer: fire, ready, aim! Beitler JJ Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1460; author reply 1460-1. PubMed ID: 12654462 [No Abstract] [Full Text] [Related]
12. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results. Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671 [TBL] [Abstract][Full Text] [Related]
13. Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lung. Shaw EG; McGinnis WL; Jett JR; Su JQ; Frank AR; Mailliard JA; Engel RE; Wiesenfeld M; Rowland KM J Natl Cancer Inst; 1993 Feb; 85(4):321-3. PubMed ID: 8381189 [No Abstract] [Full Text] [Related]
14. Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report. Bonomi P; Faber LP; Recine D; Lincoln S Semin Oncol; 1995 Aug; 22(4 Suppl 9):42-7. PubMed ID: 7644927 [TBL] [Abstract][Full Text] [Related]
15. Patterns of practice survey for nonsmall cell lung carcinoma in the U.S. Choy H; Shyr Y; Cmelak AJ; Mohr PJ; Johnson DH Cancer; 2000 Mar; 88(6):1336-46. PubMed ID: 10717614 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy. Hainsworth JD; Greco FA Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer. Choy H; Akerley W; Safran H; Graziano S; Chung C Semin Oncol; 1996 Dec; 23(6 Suppl 16):117-9. PubMed ID: 9007137 [TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant combined therapy in stage IIIA if non-small-cell bronchial cancer]. Thomas M; Rübe C; Semik M; Junker K; von Eiff M Dtsch Med Wochenschr; 1997 Aug; 122(33):993-8. PubMed ID: 9296933 [TBL] [Abstract][Full Text] [Related]
19. Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy with carboplatin, etoposide and epirubicin. Nyman CR Thorax; 1992 Aug; 47(8):668. PubMed ID: 1329248 [No Abstract] [Full Text] [Related]
20. Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer. Wang L; Wu S; Ou G; Bi N; Li W; Ren H; Cao J; Liang J; Li J; Zhou Z; Lv J; Zhang X Lung Cancer; 2012 Jul; 77(1):89-96. PubMed ID: 22418243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]